Literature DB >> 11714649

Molecular basis of downregulation of G-protein-coupled inward rectifying K(+) current (I(K,ACh) in chronic human atrial fibrillation: decrease in GIRK4 mRNA correlates with reduced I(K,ACh) and muscarinic receptor-mediated shortening of action potentials.

D Dobrev1, E Graf, E Wettwer, H M Himmel, O Hála, C Doerfel, T Christ, S Schüler, U Ravens.   

Abstract

BACKGROUND: Clinical and experimental evidence suggest that the parasympathetic nervous system is involved in the pathogenesis of atrial fibrillation (AF). However, it is unclear whether changes in G-protein-coupled inward rectifying K(+) current (I(K,ACh)) contribute to chronic AF. METHODS AND
RESULTS: In the present study, we used electrophysiological recordings and competitive reverse-transcription polymerase chain reaction to study changes in I(K,ACh) and the level of the I(K,ACh) GIRK4 subunit in isolated human atrial myocytes and the atrial tissue of 39 patients with sinus rhythm and 24 patients with chronic AF. The density of I(K,ACh) was approximately 50% smaller in myocytes from patients with AF compared with those in sinus rhythm, and this was accompanied by decreased levels of GIRK4 mRNA. The current density of the inward rectifying K(+) current (I(K1)) was 2-fold larger during AF than in sinus rhythm, in correspondence with an increase in Kir2.1 mRNA. The larger I(K1) in AF is consistent with more negative membrane potentials in right atrial trabeculae from AF patients. Moreover, action potential duration was reduced in AF, and the action potential shortening produced by muscarinic receptor stimulation was attenuated, indicating that the changes of I(K1) and I(K,ACh) were functionally relevant.
CONCLUSIONS: Chronic human AF induces transcriptionally mediated upregulation of I(K1) but downregulation of I(K,ACh) and attenuates the muscarinic receptor-mediated shortening of atrial action potentials. This suggests that atrial myocytes adapt to a chronically high rate by downregulating I(K,ACh) to counteract the shortening of the atrial effective refractory period due to electrical remodeling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714649     DOI: 10.1161/hc4601.099466

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  95 in total

1.  Single channel analysis of the regulation of GIRK1/GIRK4 channels by protein phosphorylation.

Authors:  Carmen Müllner; Daniel Yakubovich; Carmen W Dessauer; Dieter Platzer; Wolfgang Schreibmayer
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

Review 2.  Atrial fibrillation: basic mechanisms, remodeling and triggers.

Authors:  Akiko Shiroshita-Takeshita; Bianca J J M Brundel; Stanley Nattel
Journal:  J Interv Card Electrophysiol       Date:  2005-09       Impact factor: 1.900

Review 3.  [New antiarrhythmic drugs for therapy of atrial fibrillation: I. Ion channel blockers].

Authors:  U Ravens; E Wettwer; U Schotten; R Wessel; D Dobrev
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2006-06

4.  Silencing GIRK4 expression in human atrial myocytes by adenovirus-delivered small hairpin RNA.

Authors:  Xiongtao Liu; Jian Yang; Fujun Shang; Changming Hong; Wangang Guo; Bing Wang; Qiangsun Zheng
Journal:  Mol Biol Rep       Date:  2008-07-18       Impact factor: 2.316

Review 5.  Mathematical approaches to understanding and imaging atrial fibrillation: significance for mechanisms and management.

Authors:  Natalia A Trayanova
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

6.  Arrhythmias, elicited by catecholamines and serotonin, vanish in human chronic atrial fibrillation.

Authors:  Torsten Christ; Nadiia Rozmaritsa; Andreas Engel; Emanuel Berk; Michael Knaut; Katharina Metzner; Manuel Canteras; Ursula Ravens; Alberto Kaumann
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

7.  Dominant frequency increase rate predicts transition from paroxysmal to long-term persistent atrial fibrillation.

Authors:  Raphael P Martins; Kuljeet Kaur; Elliot Hwang; Rafael J Ramirez; B Cicero Willis; David Filgueiras-Rama; Steven R Ennis; Yoshio Takemoto; Daniela Ponce-Balbuena; Manuel Zarzoso; Ryan P O'Connell; Hassan Musa; Guadalupe Guerrero-Serna; Uma Mahesh R Avula; Michael F Swartz; Sandesh Bhushal; Makarand Deo; Sandeep V Pandit; Omer Berenfeld; José Jalife
Journal:  Circulation       Date:  2014-01-24       Impact factor: 29.690

Review 8.  More types than one: multiple muscarinic receptor coupled K+ currents undergo remodelling in an experimental model of atrial fibrillation.

Authors:  A F James; J C Hancox
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

Review 9.  Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target.

Authors:  Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-09-26       Impact factor: 3.000

10.  Mathematical simulations of ligand-gated and cell-type specific effects on the action potential of human atrium.

Authors:  Mary M Maleckar; Joseph L Greenstein; Natalia A Trayanova; Wayne R Giles
Journal:  Prog Biophys Mol Biol       Date:  2009-01-30       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.